Breakthrough trial aims to free kidney patients from lifelong drugs
NCT ID NCT00619528
Summary
This study tested whether kidney transplant patients could safely stop taking lifelong anti-rejection medications. Researchers gave patients stem cells from their donor sibling along with a special antibody treatment, then tried to gradually withdraw their immunosuppressive drugs. The goal was to help the body accept the new kidney without needing continuous medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Northwestern Memorial Hospital
Chicago, Illinois, 60611, United States
Conditions
Explore the condition pages connected to this study.